Ginkgo Bioworks Holdings Inc (NYSE:DNA) has a beta value of 1.32 and has seen 0.41 million shares traded in the recent trading session. The company, currently valued at $332.05M, closed the recent trade at $5.72 per share which meant it lost -$0.4 on the day or -6.51% during that session. The DNA stock price is -732.17% off its 52-week high price of $47.60 and 8.04% above the 52-week low of $5.26. If we look at the company’s 10-day average daily trading volume, we find that it stood at 1.16 million shares traded. The 3-month trading volume is 1.65 million shares.
The consensus among analysts is that Ginkgo Bioworks Holdings Inc (DNA) is Buy stock at the moment, with a recommendation rating of 3.83. 2 analysts rate the stock as a Sell, while 0 rate it as Overweight. 1 out of 5 have rated it as a Hold, with 2 advising it as a Buy. 0 have rated the stock as Underweight. The expected earnings per share for the stock is 0.
Ginkgo Bioworks Holdings Inc (NYSE:DNA) trade information
Sporting -6.51% in the red today, the stock has traded in the red over the last five days, with the highest price hit on recent trading when the DNA stock price touched $5.72 or saw a rise of 26.38%. Year-to-date, Ginkgo Bioworks Holdings Inc shares have moved -41.74%, while the 5-day performance has seen it change -25.69%. Over the past 30 days, the shares of Ginkgo Bioworks Holdings Inc (NYSE:DNA) have changed -30.56%. Short interest in the company has seen 9.98 million shares shorted with days to cover at 4.85.
Wall Street analysts have a consensus price target for the stock at $6.5, which means that the shares’ value could jump 12.0% from the levels at last check today.. The projected low price target is $4.35 while the price target rests at a high of $12.0. In that case, then, we find that the latest price level in today’s session is -109.79% off the targeted high while a plunge would see the stock lose 23.95% from the levels at last check today..
Ginkgo Bioworks Holdings Inc (DNA) estimates and forecasts
The company’s shares have lost -25.69% over the past 6 months. Revenue growth from the last financial year stood is estimated to be -23.22%.
5 analysts offering their estimates for the company have set an average revenue estimate of 39.34M for the current quarter. 5 have an estimated revenue figure of 43.62M for the next ending quarter. Year-ago sales stood 37.94M and 56.21M respectively for this quarter and the next, and analysts expect sales will grow by 3.67% for the current quarter and -23.22% for the next.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was -27.97% over the past 5 years. Earnings growth for 2025 is a modest 49.93% while over the next 5 years, the company’s earnings are expected to increase by 48.92%.
DNA Dividends
Ginkgo Bioworks Holdings Inc is expected to release its next earnings report on 2025-Feb-24 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Ginkgo Bioworks Holdings Inc (NYSE:DNA)’s Major holders
Insiders own 6.59% of the company shares, while shares held by institutions stand at 79.85% with a share float percentage of 85.49%. Investors are also buoyed by the number of investors in a company, with Ginkgo Bioworks Holdings Inc having a total of 228.0 institutions that hold shares in the company. The top two institutional holders are VIKING GLOBAL INVESTORS LP with over 143.09 million shares worth more than $47.83 million. As of 2024-06-30, VIKING GLOBAL INVESTORS LP held 6.9686% of shares outstanding.
The other major institutional holder is VANGUARD GROUP INC, with the holding of over 138.96 million shares as of 2024-06-30. The firm’s total holdings are worth over $46.46 million and represent 6.9327% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund . As of Dec 31, 2024 , the former fund manager holds about 2.55% shares in the company for having 1.17 shares of worth $6.68 million while later fund manager owns 640.67 shares of worth $3.66 million as of Dec 31, 2024 , which makes it owner of about 1.40% of company’s outstanding stock.
